Mangoceuticals (MGRX) EV to CFO (2023 - 2026)
Mangoceuticals' (MGRX) quarterly EV to CFO came in at 25.33 in Q2 2026, down 98.17% year-over-year from 1384.45 in Q2 2025, and down 461.4% quarter-over-quarter from 4.51 in Q1 2026.
Powered by 
Analysis
Mangoceuticals (MGRX) EV to CFO (2023 - 2026) Analysis & Trends
Mangoceuticals has disclosed EV to CFO across 4 years of filings, most recently posting 25.33 for Q2 2026.
- In Q2 2026, EV to CFO fell 98.17% year-over-year to 25.33; the TTM figure through Jun 2026 stood at 1.7 (up 38.47% YoY), while the FY2025 annual figure was 1.01, down 4.64% from the prior year.
- EV to CFO came in at 25.33 for Q2 2026 at Mangoceuticals, down from 4.51 in the prior quarter.
- In the past five years, EV to CFO ranged from a high of 2.18 in Q4 2023 to a low of 25.33 in Q2 2026.
- Average EV to CFO over 4 years is 8.81, with a median of 5.4 recorded in 2024.
- Year-over-year, EV to CFO jumped 65.83% in 2024 and plunged 211.26% in 2025.
- Over 4 years, EV to CFO stood at 2.18 in 2023, then plunged by 91.14% to 4.17 in 2024, then tumbled by 31.91% to 5.5 in 2025, then slumped by 360.29% to 25.33 in 2026.
- Per Business Quant data, the three most recent EV to CFO figures were 25.33 in Q2 2026, 4.51 in Q1 2026, and 5.5 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Hinge Health | 7.41 Bn | 7.03 Bn | 183.95 Mn |
| 2 | Hims & Hers Health | 6.47 Bn | 5.63 Bn | 480.80 Mn |
| 3 | Ethos Technologies | 2.54 Bn | 2.37 Bn | 185.54 Mn |
| 4 | Omada Health | 1.38 Bn | 1.16 Bn | 63.79 Mn |
| 5 | Teladoc Health | 1.14 Bn | 366.41 Mn | 416.09 Mn |
| 6 | Talkspace | 870.58 Mn | 779.48 Mn | 24.80 Mn |
| 7 | Akso Health | 259.44 Mn | 259.25 Mn | - |
| 8 | LifeMD | 147.29 Mn | 147.29 Mn | - |
| 9 | eHealth | 31.71 Mn | -69.34 Mn | - |
| 10 | Mangoceuticals | 7.39 Mn | 7.14 Mn | 44,215.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25.33 |
| Mar 31, 2026 | -4.51 |
| Dec 31, 2025 | -5.50 |
| Sep 30, 2025 | -19.93 |
| Jun 30, 2025 | -12.78 |
| Mar 31, 2025 | -3.90 |
| Dec 31, 2024 | -4.17 |
| Sep 30, 2024 | -6.40 |
| Jun 30, 2024 | -5.30 |
| Mar 31, 2024 | -5.15 |
| Dec 31, 2023 | -2.18 |
| Sep 30, 2023 | -7.62 |
| Jun 30, 2023 | -15.52 |
| Mar 31, 2023 | -5.00 |